TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Bioform AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,892
|
1,126
|
1,470 |
| Financial expenses |
12
|
12
|
3 |
| Earnings before taxes |
771
|
72
|
417 |
| Total assets |
1,837
|
1,566
|
1,418 |
| Current assets |
1,522
|
1,341
|
1,254 |
| Current liabilities |
183
|
466
|
331 |
| Equity capital |
1,654
|
1,100
|
1,087 |
| - share capital |
62
|
66
|
70 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
90.0%
|
70.2%
|
76.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
40.8%
|
6.4%
|
28.4% |
| Return on assets (ROA) |
42.6%
|
5.4%
|
29.6% |
| Current ratio |
831.7%
|
287.8%
|
378.9% |
| Return on equity (ROE) |
46.6%
|
6.5%
|
38.4% |
| Change turnover |
838
|
-267
|
721 |
| Change turnover % |
79%
|
-19%
|
96% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.